GTHX - G1 Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - GTHX (1560241)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
45 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2018-09-17
GTHXVelleca Mark A.Pres, CEOS - Sale+OE$66.31-5,0009,000-36%-$331,549
D
2018-09-17
GTHXMalik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$66.08-3,7768,400-31%-$249,502
D
2018-09-05
GTHXMoses Jennifer K.VP of Finance, AdminS - Sale+OE$59.60-7502,000-27%-$44,700
D
2018-09-04
GTHXRudnick SethDirS - Sale+OE$59.95-10,00058,282-15%-$599,483
D
2018-09-04
GTHXMurdock Terry LSVP of Development OperationsS - Sale+OE$59.98-3,5190-100%-$211,065
M
2018-08-29
GTHXStrum JayChief Scientific OfficerS - Sale$59.60-10,00048,569-17%-$595,971
D
2018-08-15
GTHXMalik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$55.89-3,7768,400-31%-$211,023
D
2018-08-15
GTHXVelleca Mark A.Pres, CEOS - Sale+OE$55.88-5,0009,000-36%-$279,378
D
2018-08-06
GTHXRudnick SethDirS - Sale+OE$50.69-10,00058,282-15%-$506,901
D
2018-08-06
GTHXMoses Jennifer K.VP of Finance, AdminS - Sale+OE$50.79-7500-100%-$38,093
D
2018-08-03
GTHXMurdock Terry LSVP of Development OperationsS - Sale+OE$50.60-3,5190-100%-$178,061
D
2018-07-16
GTHXMalik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$42.17-3,7768,400-31%-$159,248
D
2018-07-16
GTHXVelleca Mark A.Pres, CEOS - Sale+OE$42.06-5,0009,000-36%-$210,313
D
2018-07-05
GTHXMoses Jennifer K.VP of Finance, AdminS - Sale+OE$45.66-7500-100%-$34,245
D
2018-06-15
GTHXMalik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$44.31-3,7768,400-31%-$167,326
D
2018-06-05
GTHXMoses Jennifer K.VP of Finance, AdminS - Sale+OE$38.77-7500-100%-$29,078
2018-05-30
GTHXThorp Clay10%S - Sale$48.00-800,0003,237,711-20%-$38,400,000
M
2018-05-21
GTHXThorp Clay10%S - Sale$51.11-37,5004,037,711-1%-$1,916,678
D
2018-05-15
GTHXVelleca Mark A.Pres, CEOS - Sale+OE$46.28-7,5000-100%-$347,064
D
2018-05-15
GTHXMalik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$46.30-3,7764,200-47%-$174,821
D
2018-05-07
GTHXMoses Jennifer K.VP of Finance, AdminS - Sale+OE$45.00-7500-100%-$33,750
D
2018-04-16
GTHXVelleca Mark A.Pres, CEOS - Sale+OE$36.00-7,5000-100%-$269,971
D
2018-04-16
GTHXMalik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$36.05-3,7764,200-47%-$136,135
D
2018-04-05
GTHXMoses Jennifer K.VP of Finance, AdminS - Sale+OE$37.47-7500-100%-$28,103
D
2018-03-15
GTHXVelleca Mark A.Pres, CEOS - Sale+OE$38.20-7,5000-100%-$286,466
D
2018-03-15
GTHXMalik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$38.18-3,7764,200-47%-$144,151
D
2018-03-05
GTHXMoses Jennifer K.VP of Finance, AdminS - Sale+OE$26.55-7500-100%-$19,913
D
2018-02-15
GTHXVelleca Mark A.Pres, CEOS - Sale+OE$20.00-7,5000-100%-$150,015
D
2018-02-15
GTHXMalik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$20.00-3,7760-100%-$75,520
D
2018-02-05
GTHXMoses Jennifer K.VP of Finance, AdminS - Sale+OE$22.99-7500-100%-$17,243
D
2018-01-16
GTHXVelleca Mark A.Pres, CEOS - Sale+OE$22.99-7,5000-100%-$172,395
D
2018-01-16
GTHXMalik RajeshCh. Medical Officer, SVP R, DS - Sale+OE$22.96-3,7760-100%-$86,693
D
2018-01-05
GTHXMoses Jennifer K.VP of Finance, AdminS - Sale+OE$19.96-7500-100%-$14,970
D
2017-12-18
GTHXVelleca Mark A.Pres, CEOS - Sale+OE$20.01-7,5000-100%-$150,106
2017-12-15
GTHXMedimmune Ventures, Inc.10%S - Sale$19.75-200,0002,950,630-6%-$3,950,000
A
2017-05-17
GTHXMedimmune Ventures, Inc.10%P - Purchase$15.00+75,0003,409,536+2%+$1,125,000
2017-12-01
GTHXMedimmune Ventures, Inc.10%S - Sale$19.75-133,9063,150,630-4%-$2,644,644
2017-11-20
GTHXMedimmune Ventures, Inc.10%S - Sale$20.01-200,0003,284,536-6%-$4,002,000
D
2017-11-13
GTHXEshelman Fredric NDir, 10%P - Purchase$19.73+250,0003,689,151+7%+$4,932,500
D
2017-05-22
GTHXEshelman Ventures, LLC10%P - Purchase$15.00+300,0003,439,151+10%+$4,500,000
D
2017-05-22
GTHXThorp Clay10%P - Purchase$15.00+133,3334,173,729+3%+$1,999,995
D
2017-05-22
GTHXEshelman Fredric NDir, 10%P - Purchase$15.00+300,0003,439,151+10%+$4,500,000
D
2017-05-22
GTHXMuir Glenn PDirP - Purchase$15.00+20,000120,969+20%+$300,000
D
2017-05-22
GTHXMedimmune Ventures, Inc.10%P - Purchase$15.00+75,0003,484,536+2%+$1,125,000
D
2017-05-22
GTHXRa Capital Management, LLCFmr 10% Owner See Footnote (2)P - Purchase$15.00+400,0004,968,488+9%+$6,000,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top